Noninvasive methodologies for measuring carcinogen expoure in humans, based on the use of urinary markers, are being developed and validated for use in molecular epidemiological studies. A range of3-alkyladenines can be determined in urine samples by an immunoafflnty puriflcation-GC/MS approach [3-methyladenine, 3-ethyladenine, 3-(2-hydroxyethyl)adenine, and 3-benzyladeninel. Using this method, recent results in human subjects suggest that urinary 3-alkyladenines are potentially usefl markers ofalkylating agent exposure, particularly where the backgrounds of such adducts are much lower than 3-methyladenine. Urinary excretion of S-benzylmercapturic acid has been studied in experimental animals as a marker ofexposure to benzylatingagents such as N-nitroso-methylbenzylamine. 3-Nitrotyrosine (NTyr) is formed in vivo in tissue or blood proteins after exposure to nitrosating and/or nitrating agents such as tetranitromethane. After turnover of proteins, NTyr is released and excreted in urine as metabolites 3-nitro-4-hydroxyphenylacetic aad and 3-nitro-4-hydroxyphenylacetic acid, which are determined by GC with a thermal energy analyzer. The sensitivity and specificit, combined with ease of use, of these noninvasive bimonitoring approaches means that they may be readily inorporated into molecular epidemiological studies in which qxpue to nitrosating and alkylating agents may be important risk factors.